Axios on MSN32m
Signs of optimism for biopharma at JPM conferenceAfter several years in the doldrums, pharmaceutical companies and biotechs expect an uptick in dealmaking in 2025, with some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback